Relapse Risk of Endometrial Hyperplasia After Treatment With the Levonorgestrel-Impregnated Intrauterine System or Oral Progestogens

Relapse Risk of Endometrial Hyperplasia After Treatment With the Levonorgestrel-Impregnated Intrauterine System or Oral Progestogens

(Abstracted from BJOG 2016;123:1512–1519)This study assesses the effectiveness of oral progestogen therapy for non–atypical endometrial precursor lesions, which could develop into endometrial cancer. Surgery is not always the prescribed treatment as there is a very low risk of progression of the pre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obstetrical & gynecological survey 2016-08, Vol.71 (8), p.465-466
Hauptverfasser: Ørbo, A, Arnes, M, Vereide, A B, Straume, B
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:(Abstracted from BJOG 2016;123:1512–1519)This study assesses the effectiveness of oral progestogen therapy for non–atypical endometrial precursor lesions, which could develop into endometrial cancer. Surgery is not always the prescribed treatment as there is a very low risk of progression of the precursor lesions to endometrial cancer (
ISSN:0029-7828
1533-9866
DOI:10.1097/OGX.0000000000000349